Mark Ziemann
Impact in
- Molecular Biology top 5%
- Gut microbiota and health
- Epigenetics and DNA Methylation
- Extracellular vesicles in disease
- Congenital heart defects research
- RNA modifications and cancer
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 12
- RNA modifications and cancer 10
- Mitochondrial Function and Pathology 7
- RNA Research and Splicing 6
- Cancer-related gene regulation 5
- Histone Deacetylase Inhibitors Research 5
- Co-authors
- Assam El‐Osta (45 shared papers)Antony Kaspi (24 shared papers)Mrinal Bhave (10 shared papers)April Fiedler (3 shared papers)Po‐Yin Chu (2 shared papers)Francine Z. Marques (3 shared papers)Niwanthi W. Rajapakse (2 shared papers)Charles R. Mackay (3 shared papers)
In The Last Decade
Mark Ziemann
87 papers receiving 3.6k citations
Mark Ziemann's Hit Papers
Peers
Comparison fields: 5 of 154
- Molecular Biology 2.3k
- Cancer Research 397
- Physiology 590
- Biological Psychiatry 49
- Horticulture 16
Countries citing papers authored by Mark Ziemann
This map shows the geographic impact of Mark Ziemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ziemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ziemann more than expected).
Fields of papers citing papers by Mark Ziemann
This network shows the impact of papers produced by Mark Ziemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ziemann. The network helps show where Mark Ziemann may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ziemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice Hit paper breakdown → | 2016 | 809 |
| 2 | 2012 | 396 | |
| 3 | 2017 | 189 | |
| 4 | 2011 | 163 | |
| 5 | 2013 | 153 | |
| 6 | 2009 | 148 | |
| 7 | 2015 | 111 | |
| 8 | 2009 | 109 | |
| 9 | 2016 | 87 | |
| 10 | 2016 | 77 | |
| 11 | 2021 | 70 | |
| 12 | 2014 | 66 | |
| 13 | 2018 | 64 | |
| 14 | 2013 | 62 | |
| 15 | 2015 | 59 | |
| 16 | 2022 | 56 | |
| 17 | 2009 | 52 | |
| 18 | 2014 | 51 | |
| 19 | 2018 | 47 | |
| 20 | 2015 | 47 |
About Mark Ziemann
Mark Ziemann is a scholar working on Molecular Biology, Plant Science, Physiology, Immunology and Clinical Biochemistry, having authored 95 papers that have together received 3.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), RNA modifications and cancer (10 papers), Mitochondrial Function and Pathology (7 papers), RNA Research and Splicing (6 papers), Diet and metabolism studies (6 papers), Advanced Glycation End Products research (5 papers), Cancer-related gene regulation (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Molecular Biology (2.3k citations), Cancer Research (397 citations), Physiology (590 citations), Biological Psychiatry (49 citations) and Horticulture (16 citations). Mark Ziemann has collaborated with scholars based in Australia, China and Hong Kong. Frequent co-authors include Assam El‐Osta, Antony Kaspi, Mrinal Bhave, April Fiedler, Po‐Yin Chu, Francine Z. Marques, Niwanthi W. Rajapakse, Charles R. Mackay, David M. Kaye and Duncan Horlock. Their work appears in journals such as Epigenetics, PLoS ONE, International Journal of Molecular Sciences, The FASEB Journal and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.